Hereditary hemochromatosis: Difference between revisions

From IDWiki
(Imported from text file)
 
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
 
Line 20: Line 20:
* 10% of those homozygous for C282Y develop symptoms
* 10% of those homozygous for C282Y develop symptoms


== Clinical Presentation ==
== Clinical Manifestations ==


=== History ===
=== History ===

Latest revision as of 01:44, 21 July 2020

Definition

Recessive genetic disorder to iron handling that is characterized by elevated iron saturation and high ferritin and that causes progressive end-organ damage, most commonly liver, pancreas, and heart.

Etiology

  • Most commonly caused by homozygous C282Y mutation of the HFE gene
    • Only 10% of homozygotes will have iron overload
  • Can also present in compound heterozygotes of HFE gene
  • Non-HFE-associated iron overload
    • Hemojuvelin (HJV)
    • Transferrin receptor-2 (TfR2)
    • Ferroportin (SLC40A1)
    • Hepcidin (HAMP)
    • African iron overload

Epidemiology

  • Most common genetic cause of cirrhosis
  • 10% of those homozygous for C282Y develop symptoms

Clinical Manifestations

History

  • Asymptomatic
    • Abnormal serum iron studies on routine screening chemistry panel
    • Evaluation of abnormal liver tests
    • Identified by family screening
  • Nonspecific, systemic symptoms
    • Weakness
    • Fatigue
    • Lethargy
    • Apathy
    • Weight loss
  • Specific, organ-related symptoms
    • Abdominal pain (hepatomegaly)
    • Arthralgias (arthritis)
    • Diabetes (pancreas)
    • Amenorrhea (cirrhosis)
    • Loss of libido, impotence (pituitary, cirrhosis)
    • Congestive heart failure
    • Arrhythmias

Physical exam

  • Liver
    • Hepatomegaly
    • Cutaneous stigmata of chronic liver disease
    • Splenomegaly
    • Liver failure: ascites, encephalopathy, and associated features
  • Joints Arthritis
    • Joint swelling
    • Chondrocalcinosis
  • Heart
    • Dilated cardiomyopathy
    • Congestive heart failure
  • Skin
    • Increased pigmentation
    • Porphyria cutanea tarda
  • Endocrine
    • Testicular atrophy
    • Hypogonadism
    • Hypothyroidism

Investigations

graph TD;

invest["Serum transferrin saturation (TS) and ferritin"]

tsnorm["TS <45% and normal ferritin"]
tsup["TS ≥45% and/or high ferritin"]
fhx["First-degree relative with HH"]
noeval["No further evaluation"]
genotype["HFE genotyping"]

invest --> tsnorm
tsnorm --> noeval

invest --> tsup
tsup --> genotype

fhx --> genotype
  • Initial workup is ferritin and serum transferrin saturation
    • If ferritin is above upper limit of normal, or if transferrin saturation is ≥45%, then do HFE mutation analysis
    • Transferrin saturation = serum iron concentration ÷ total iron binding capacity
  • HFE mutation analysis
    • Done for all first-degree relatives of an index case
    • Done for all patients with elevated ferriting or TS ≥45%
    • Important results:
      • Homozygous C282Y
      • Compound heterozygous C282Y/H63D
      • Homozygous H63D/H63D generally don't have iron overload
  • Iron/transferrin saturation >60% in men or >50% in women
    • Most sensitive and cost-effective test
  • If cirrhosis develops, monitor closely for hepatocellular carcinoma

Management

  • Phlebotomy to target ferritin of 50-100
    • But need to prevent hematocrit or hemoglobin dropping more than 20% of prior level

Further Reading